Biomarker discovery in asthma-related inflammation and remodeling. by Quesada Calvo, Florence(*) et al.
Published in: Proteomics (2009) 
Status: Postprint (Author’s version) 
Biomarker discovery in asthma-related inflammation and remodeling 
 
Florence Quesada Calvo1,*, Marianne Fillet2,*, Dominique de Seny3, Marie-Alice Meuwis2, Raphael Marée4, 
Céline Crahay1, Geneviève Paulissen1, Natacha Rocks1, Maud Gueders1, Louis Wehenkel5, Marie-Paule 
Merville2, Renaud Louis6, Jean-Michel Foidart1, Agnes Noël1 and Didier Cataldo1 
 
1  Laboratory of Biology of Tumours and Development, University of Liège and Centre Hospitalier Universitaire (CHU-Liège), Belgium 
2 Laboratory of Medical Chemistry, University of Liège and Centre Hospitalier Universitaire (CHU-Liège), Belgiur 
3 Laboratory of Rheumatology, University of Liège and Centre Hospitalier Universitaire (CHU-Liège), Belgium 
4 GIGA-Management, Plateforme bioinformatique, University of Liège and Centre Hospitalier Universitaire (CHU-Liège), Belgium 
5 Department of Electrical Engineering & Computer Sciences, University of Liège and Centre Hospitalier Universitaire (CHU-Liège), 
Belgium 




Asthma is a complex inflammatory disease of airways. A network of reciprocal interactions between 
inflammatory cells, peptidic mediators, extracellular matrix components, and proteases is thought to be involved 
in the installation and maintenance of asthma-related airway inflammation and remodeling. To date, new proteic 
mediators displaying significant activity in the pathophysiology of asthma are still to be unveiled. The main 
objective of this study was to uncover potential target proteins by using surface-enhanced laser 
desorption/ionization-time of flight-mass spectrometry (SELDI-TOF-MS) on lung samples from mouse models 
of allergen-induced airway inflammation and remodeling. In this model, we pointed out several protein or 
peptide peaks that were preferentially expressed in diseased mice as compared to controls. We report the 
identification of different five proteins: found inflammatory zone 1 or RELMα (FIZZ-1), calcyclin (S100A6), 
clara cell secretory protein 10 (CC10), Ubiquitin, and Histone H4. 
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1    Introduction 
Asthma is mainly characterized by reversible airway obstruction, airway hyperresponsiveness, and chronic 
airway inflammation [1]. As asthma becomes persistent, permanent changes of airway walls, referred to as 
"bronchial remodeling" caused by long-standing asthma-related-inflammation, progressively develop [2-4]. 
These structural changes are thought to be responsible for asthma-related bronchial hyperresponsiveness [1] and 
to play key roles in the progressive decline of lung function reported in chronic asthma [5]. Albeit airway 
remodeling is a clinically relevant problem, mechanisms leading to this disease component through the 
activation of biological networks including airway epithelial cells, inflammatory cells, cytokines, other peptidic 
mediators, and proteases have not yet been elucidated. During the last decade, murine models of allergen-
induced inflammation and hyperresponsiveness have been used to reliably explore disease mechanisms [2, 3]. 
Proteome studied under normal and diseased conditions provides a realistic view of different proteins taking part 
to biological processes and might link genome sequences with cellular behaviors. 
In order to investigate which peptidic mediators are susceptible to take part to asthma progression, we used 
SELDI-TOF-MS technology. This ProteinChip platform was used to establish expression profiles for low 
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molecular weight proteins and to highlight new potential biomarkers. Different ProteinChips have been designed 
to selectively retain a category of proteins from biological samples according to their biochemical properties and 
MS is applied on these samples leading to characteristic peak patterns [6-11]. 
The main objective of the current study was to define protein profiles in mouse models of allergen-induced 
airway inflammation and remodeling by using SELDI-TOF-MS in order to identify which peptides are the most 
relevant to discern inflamed or remodeled bronchi from normal lung tissue. 
2    Material and methods 
2.1  Mice 
Specific pathogen-free Balb/c mice (6 wk old, male) were used. Two different protocols consisting in acute 
(short term) or chronic (long term) exposure to allergen were applied. Both protocols were approved by the 
Veterinary Ethical Committee ofthe University of Liège. In acute inflammation experiments (IM), mice were 
sensitized by intraperitoneal injection of 10 µg ovalbumin grade V (OVA) (Sigma, Germany) adsorbed on 
Al(OH)3 (Alumlnject©, Perbio, Belgium) on days 1 and 7. Animals were either challenged by 1% OVA - 
phosphate saline buffer (PBS) aerosols of suspended in or with PBS alone for 30 min on days 23 to 27 as 
previously described in Gueders et al [4]. Each experiment was performed with placebo mice (n = 20) and 
allergen-exposed mice (n = 20). 
In the chronic remodeling allergen exposure protocol (RM), allergen sensitization, and exposure were followed 
by additional allergen or PBS exposures performed 5 days per even week, until day 90. Each experiment was 
performed with placebo mice (n = 20) and allergen-exposed mice (n = 20). For further details on the 
characterization of allergen-induced inflammation and airway responsiveness see Supporting Information. 
2.2  SELDI-TOF-MS analysis 
Total proteins were extracted from lungs by incubating crushed tissue with lysis buffer containing 7 M Urea, 2 
M Thiourea, 2% CHAPS, and 50 mM Tris (pH 9). Each protein sample was diluted in acetate buffer pH 4 (100 
mM) at a final protein concentration of 0.5 µg/µl. Weak cation-exchanger (CM10) ProteinChip® Arrays 
(BioRad, USA) were activated with 10 mM HCl for 5 min. CM10 arrays were then equilibrated with binding 
buffer (100 mM sodium acetate, 30 mM sodium chloride, pH 4) for 5 min. Five microliters of each sample were 
loaded per spot of CM 10 arrays and incubated in a humidity chamber for 1 h. Spots were then washed twice 
with binding buffer for 5 min, in order to eliminate non-specifically retained proteins. Two additional washes 
with acetate buffer pH 4 for 5 min were followed by two quick rinses with deionized water. All surfaces were 
air-dried during 20 min. Then, 1 µL of satured solution of matrix (sina-pinic acid (SPA) in 50% ACN, TFA 0.5% 
in water) was applied on each spot. During SELDI-TOF-MS experiments, proteins or peptides retained on the 
spot surfaces were ionized, desorbed, and detected by a Protein Biological System II ProteinChip reader 
(BioRad). 
Protein chips were all analyzed with the same settings: laser intensity at 195, detection sensitivity at 8, and 180 
shots per sample. Peaks were analyzed between m/z ranging from 2000 to 30 000 Da. Spectra were calibrated 
externally using All-in-one Peptide standard (BioRad) complemented by myoglobin (MW 16 951.5 Da) and 
cytochrome c (MW 12 360 Da) as described in ref [6, 11]. Baseline substraction, normalization on TIC, and peak 
detection were performed as described previously [6, 11]. 
2.3  Protein purification for biomarkers identification 
Spin columns CM ceramic HyperD F sorbent (BioRad) were centrifuged at 1000 rpm for 30 s. After washing 
steps in appropriate binding buffers, columns were loaded with 500 µg of total protein extract and were 
incubated for 40 min at room temperature. Bound proteins were eluted with a step gradient of sodium sulfate 
(100-500 mM) in binding buffer. Each eluate was split in two aliquots: one analyzed on CM10 array with 
SELDI-TOF-MS and the other one was used for protein identification (SDS-PAGE 1-D separation followed by 
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2.4  Immunoprecipitation 
Proteins (300 µg) from lung were incubated with 20 µg of a found inflammatory zone 1 or RELMα (FIZZ-1) 
antibody (Chemicon, USA) for 1 h at 4°C. Then, proteins coupled to an antibody were added to 40 µL of Protein 
G PLU S-Agarose (Santa Cruz Biotechnology, USA) for 2 h at 4°C. After washes with PBS + 0.5% Triton, 
pellet and proteins were resuspended in acetic acid 100 mM containing 20% ACN. Proteins were completely air 
dried and resuspended in binding buffer (100 mM sodium acetate, 30 mM sodium chloride, pH 4). 
2.5  Western blotting 
Western blots were performed with lung tissue proteins that were also used for CM10 SELDI-MS profiling. 
Lung protein sample (20 µg) and molecular weight markers (Invitrogen, 'Multimark' 3-185 kDa, USA) were 
separated under reducing conditions using NuPage 12% Bis-Tris Gels (Invitrogen), transferred, and incubated 
with primary antibodies: rabbit anti-RELMα (FIZZ-1) (Chemicon) (1/1000), rabbit anti-clara cell secretory 
protein 10 (CC10) (Santa Cruz Biotechnology) (1/2000), rabbit anti-Calcyclin (S100A6) (Santa Cruz 
Biotechnology) (1/500), rabbit anti-Histone H4 (Upstate, Bio-connect, Netherlands), and rabbit anti-Ubiquitin 
(Santa Cruz Biotechnology) (1/200). Incubation with a secondary swine anti-rabbit (Dako, Denmark) antibody 
conjugated with HRP was followed by detection with the ECL kit (Perkin Elmer, USA) as recommended by the 
manufacturer. 
The intensity of each band was measured with the Quantity One software (BioRad). Protein levels were 
normalized using β-actin signal used as an internal standard. 
2.6  Immunohistochemistry 
Endogenous peroxidase activity was blocked by incubation of tissue sections in 3% hydrogen peroxide (H2O2). 
For alpha smooth muscle actin (αSMA) staining, slides were permea-bilized in 1% Triton X-100/PBS and 
nonspecific binding was blocked in normal goat serum (FIZZ-1, CC10 and S100A6) or in 10% BSA (αSMA and 
Ubiquitin). Tissue sections were then incubated with rabbit anti-RELMα (FIZZ-1) (1/150) (Chemicon), rabbit 
anti-CCSP (CC10) (1/2000) (Seven Hill bioreagent), rabbit anti-Calcyclin (S100A6) (1/100) (Santa Cruz 
Biotechnology), rabbit anti-Ubiquitin (Santa Cruz Biotechnology) (1/400), or mouse anti-α SMA (1/200) 
(Dako). Secondary antibodies were an anti-FITC-POD (Roche, USA) (αSMA) or biotin-coupled secondary 
antibody (Dako) (FIZZ-1, CC10, S100A6, and Ubiquitin). Peroxidase activity was revealed using 3-amino, 9-
ethyl-carbazole (AEC) (Dako) staining (αSMA) or a 3-3'diaminobenzidine hydrochloride kit (DAB) (Dako) after 
incubation with a streptavidin/HRP complex (Dako). 
2.7  Statistical analyses 
2.7.1   SELDI-TOF-MS 
Before statistical analysis, preprocessing of spectra involved calibration, baseline substraction, and normalization 
of all spectra [6]. Peak detection was performed using ProteinChip Biomarker Wizard software 3.0 (BioRad). 
For peak detection, 
S/N used was 5; for cluster completion, cluster mass selected was 0.3%, and the S/N for the second pass was set 
at 3. 
2.7.2   Univariate analysis 
This statistical approach determines if the intensity of a peak is significantly different in the experimental group 
spectrum as compared to controls, p-values associated with every peak were calculated using nonparametric 
Mann-Whitney U-test (labeled when significant: p<0.05). 
2.7.3   Multivariate analysis 
This approach was previously described by Geurts et al [12]. Machine learning method (Extra-Trees Decision 
Tree) was used to build classification models and rank biomarkers, to the information that they bring into the 
classification model [12]. Biomarkers were thus ranked according to their importance (%) provided by the 
machine learning method. Leave-one-out cross validation was used to provide the mis-classification error rate, as 
well as, calculation of sensitivity and specificity. Sensitivity is defined as a percentage of samples from the target 
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class that are correctly classified by the model (true positives), while specificity represents the percentage of 
samples from the other group that are well classified (true negatives). Error rate is the percentage of samples that 
are misclassified by the model. 
2.7.4   Western blotting - immunohistochemistry -ELISA 
Comparison between groups (n = 20/group) was performed by Mann-Whitney test. Results are expressed as 
mean ± SEM. p-values <0.05 were considered as statistically significant. 
3    Results and discussion 
Development of asthma implies complex networks involving different structural and inflammatory cell types and 
mediators of both peptidic (cytokines, growth factors...) and lipidic (eicosanoïds, leukotriens...) nature. In the 
present study, the use of an inbred mice disease model allowed substantial decrease of inter-individual variations 
and thorough disease characterization [13-15]; while studies using human samples are quite limited, being 
restricted to accessible fluids such as bronchoalveolar lavages or plasma [10, 16, 17]. Nevertheless, even in 
studies using inbred mice, an intrinsic variability is expected regarding the development of main asthma 
characteristics since genetic background is not the only factor that explains the development of this disease. 
Indeed, in human monozygotic twin pairs, the concordance rate for the development of asthma is only 19% [18]. 
For these reasons, we were prone to use groups of 20 mice in the present study in order to overcome the intrinsic 
variability of this complex biological process. Proteins such as cytokines, chemokines, growth factors, and 
proteolytic fragments of larger proteins display low molecular weights. As these low molecular weight mediators 
are not easily accessible by SDS-PAGE studies, we chose to use the SELDI-TOF-MS technology. This 
technique is particularly suited to discern intensity changes in peaks corresponding to peptides and small proteins 
(<30 kDa). We therefore hypothesized that SELDI-TOF-MS could be a suitable tool for the identification of 
novel biomarkers in asthma. SELDI also offers the advantages of being compatible with high throughput 
screening, while requiring small sample volumes. We first characterized allergen-induced inflammation and 
airway responsiveness of both mice models (Supporting Information Fig. SI). Then, reproducibility of our 
proteomic studies was one of our main concerns. Multiple measurements (three replicates) were performed to 
assess the reproducibility of SELDI-TOF experiments. We used very standardized and controlled process for 
samples collection, storage, and preparation: storage at -80°C, without any defrost before proteomics analysis, 
standardization of procedures for sample, and quality control processing and ProteinChip assay preparation. 
3.1  Lung tissue protein profiling 
In order to determine which proteins (MW <30 kDa) were differentially expressed in both mice models, CM10 
ProteinChip arrays were used as described in Materials and Methods section. After optimization of experimental 
conditions, a quality control lung sample was loaded on eight spots of this array and repeatability was assessed 
and found to be satisfactory: variation coefficients of quality control peak intensity were calculated on 10 peaks 
randomly taken within 2000-30 000 Da mass range (5.5-14.2%; n = 8). Throughout the study, variation 
coefficients of peak intensity were also measured to evaluate reproducibility of experiments (3.1-17.8%; 3 days). 
For this study, each sample was loaded in triplicate and 240 spectra were collected on CM10 arrays. One 
hundred and thirteen peaks ranging from m/z 2000 to 30 000 Da were detected per spectrum with the Biomarker 
Wizard software, m/z ranging from 0 to 2000 Da was excluded from analysis to eliminate saturating background 
noise from the matrix. Representative examples of spectra are shown in Fig. 1. 
Spectra corresponding to allergen challenged mice were compared to those obtained from control mice. A 
multiple decision tree analysis (Extra-Trees) was used to assess the sensitivity and the specificity of 
classification model built with peaks profiles detected in protein extracts prepared with acute inflammation and 
chronic remodeling mice models. This statistical approach followed by a leave-one-out procedure, lead to very 
high sensitivity and specificity. We obtained a discriminatory model with a sensitivity of 95% and 80%, a 
specificity of 95% and 74% and an accuracy of 5% and 23% for acute model and remodeling model, 
respectively. Biomarkers for each model were ranked according to their discriminatory power or importance, 
expressed in percents (Table 1). For these potential biomarkers, p-values obtained by univariate analysis were 
also provided (Table 1). 
In order to identify proteins corresponding to discriminatory peak obtained by SELDI-TOF-MS analysis, SDS-
PAGE was used before tryptic digestion and fragmentation by LC-MS/MS of the peptide digests. A 
concentration step using CM 10 columns was required to identify some of the proteins from chronic remodeling 
model. Indeed, CM ceramic HyperD F sorbent mimics binding characteristics of the ProteinChip CM10 array 
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and thus isolates our potential biomarkers. 
Searches on databases performed with MASCOT 56.0 allowed the identification of five different proteins. Peaks 
at m/z 9429, 6445, 4469, 4066, and 8134 were identified by MS/ MS as FIZZ-1 (9429 Da), S100A6 (6445 Da), 
CC10 (4469 Da), Histone H4 (4066 Da), and Ubiquitin (8134 Da), respectively (Supporting Information Table 
SI). These peaks or biomarkers showed high discriminatory power in multi variate and univariate statistical 
analysis (Table 1). FIZZ-1, S100A6, CC10, and Ubiquitine displayed higher peak intensities on SELDI spectra 
in allergen-exposed versus control animals, while the inverse was observed for His-tone H4. Ubiquitin showed a 
1.1% of importance and a p-value of 3.6 × 10-4 in acute inflammation model. In chronic remodeling model, p-
values for S100A6, CC10, Histone H4 were also significant (3.48 × 10-6, 2.14 × 10-6, 0.05, respectively; data not 
shown). As expressed in Table 1, we found a relatively low number of peaks undergoing an overlapping 
modulation in our two models (acute inflammatory model and chronic remodeling model). This is mainly due to 
the fact that only ten most significant peaks after multivariate analysis have been presented for each model in this 
table. However, when we consider greater numbers of potential biomarkers (with lower statistical scores in the 
multivariate analysis), many proteins appear to be detected in both models (data not shown). Another reason for 
this apparent discrepancy might be the intrinsic differences that exist between the two models displaying 
contrasted pictures regarding inflammation and airway remodeling rendering the finding of different mediators 
quite expected. 
 
Table 1. : Potential biomarkers ranked according to their importance calculated for the IM and RMallergen-
exposed mice versus placebo comparison 
Inflammation model Remodeling model 
m/z % of importance p-values m/z % of importance p-values 
9429 15.8 <10-12 6490 5.7 2 x 10-9 
6445 11.5 <10-12 6223 4.6 4 x 10-9 
6644 7.1 <10-12 3749 3.9 9 x 10-7 
7081 6 <10-12 8134 3.6 2 x 10-8 
6226 5.2 1.10-7 3996 3 1  x 10-6 
8579 5.1 <10-12 2947 3 1 x 10-8 
4469 3.8 <10-12 3096 3 4.5 x 10-3 
4066 2.8 2.10-8 4205 2.8 6 x 10-7 
2762 2.5 <10-12 4450 2.8 2 x 10-6 
8407 2.3 <10-12 3479 2.6 2 x 10-8 
4782 2.2 3.10-9 8194 2.6 3 x 10-7 
Percentage of importance is the relative contribution of the m/z value or peaks obtained by Extra-Trees decision tree (multivariate analysis), 
p-values associated with every potential biomarker are determined by the Mann-Whitney U-test (univariate analysis). The m/z labeled in bold 
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Figure 1. SELDI-TOF-MS profiles of mouse lung proteins. Lung protein extract of 2.5 µg from placebo and 
allergen-exposed mice (IM and RM) were profiled by SELDI-TOF-MS. Representative placebo and allergen-
exposed mice from inflammation model in gel view and profiles ranging from m/z 2000 to 10 000 are shown. 
 
3.2 Validation of identified biomarkers by Western blot and immunohistochemistry 
In order to confirm the relevance of proteins identified by SELDI-TOF-MS, Western blot analyses were 
performed on each protein sample used for SELDI studies. In our acute inflammation model, the peak displaying 
the highest importance in our discriminating multivariate model corresponds to FIZZ-1. Western blotting signal 
corresponding to FIZZ-1 protein was upregulated in allergen-exposed mice (Fig. 2A) and was found 
significantly higher in acute inflamed lung as compared to the model of chronic remodeling (Fig. 2A). 
Immunohistochemistry performed on lung tissue also showed increased binding of anti-FIZZ-1 antibody (Fig. 
2B panels A-D). In the remodeling model (panels C-D), FIZZ-1 staining was restricted to the airway epithelium 
while mesenchymal and inflammatory cells were also positive in the acute model (panels A-B). In order to 
confirm that the peak at m/z 9429 actually corresponds to FIZZ-1 protein, we also performed a specific 
immunoprecipitation with an anti-FIZZ-1 antibody and further analyzed immu-noprecipitates on CM 10 
ProteinChip array (Fig. 3). After immunoprecipitation, peak at m/z 9429 was observed in SELDI-TOF-MS 
profile while not in the negative control. PCR analyses were also carried out to assess FIZZ-1 mRNA expression 
and showed a significant increase (p<0.01) after acute allergen exposure as compared to controls (0.14 ± 0.04 
and 0.5 ± 0.08, respectively, data not shown). It is the first time that FIZZ-1 is identified in tissue by SELDI-
TOF-MS. FIZZ-1 is a secreted cytokine that was previously reported to be increased in bronchoalveolar lavage 
from infectious-exposed mice [19]. The production of FIZZ-1 was reported to be under the dependence of Th2 
cytokines: IL-4 and IL-13, being themselves mainstay of asthma-related inflammatory cascade [20]. Moreover, 
the Th2 cytokine IL-21 stimulates FIZZ-1 production by alveolar macrophages under the dependence of IL-4 
and IL-13 [21]. Therefore, our data indicate that FIZZ-1 could indeed be related to the Th2 cytokine network. 
More than being a biomarker, FIZZ-1 might also be an effector in asthma, since this protein has been reported to 
induce fibroblast differentiation into myofibroblasts, producing type I collagen and SMA and playing a role in 
airway remodeling in asthma [22]. Based on these data, we propose Fizz-1 as a biomarker of asthma. 
In this work, we also described that intensity of peak corresponding to CC10 is significantly increased in animals 
exposed to allergens. CC10 is produced mainly but not exclusively by Clara cells and can be detected in organs 
communicating with the external environment (i.e., urogenital tract) [23]. The exact biological functions of 
CC10 are still unknown. By SELDI-TOF-MS, we detected CC10 as 5 kDa fragments in lung tissue. In line with 
our study, other authors have reported a 5 kDa isoform in nasal lavages from patients exposed to chemicals in 
professional environment [24]. Western blot analysis for CC10 revealed increased signal intensities in samples 
from allergen-exposed mice in both models (p<0.001 for IM and p<0.05 for RM, Fig. 2A), CC10 was detected 
by immunohis-tochemistry mostly in bronchial epithelium (Fig. 2B, panels E-H). 
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Figure 2. (A) Confirmation of biomarkers by Western blotting: Four representative samples in each group are shown. By contrast, 
statistical analyses were performed on all samples. Significant increase of FIZZ-1, CC10, and Ubiquitin protein signal in mice exposed to 
allergen confirmed SELDI-TOF-MS results. An enhanced S100A6 protein expression was observed after specific Western blotting but 
without reaching significance. Histone H4 protein expression is significantly decreased in allergen-exposed mice compare to the placebo-
exposed mice, like obtained by SELDI-TOF-MS. All Western blotting signals were normalized against relevant β actin intensity (data not 
shown). (B) Histological analysis of lung: Panels A-D show Fizz-1 labeled lung sections (10 fields) from placebo-challenged mice (A and C) 
and from allergen-challenged mice (B and D). In bronchial epithelium, alveolar macrophages and type II pneumocytes are present in 
inflamed lung but not in the control lung, FIZZ-1 proteins were strongly positive. The protein expression was less pronounced in long-term 
allergen-exposed mice. An increased of CC10 signal can be found in lung tissue in short-term allergen-exposed mice (F). The allergen 
exposure leads to enhancement of S100A6 production (J and L). Quantification data of FIZZ-1, S100A6, and Ubiquitin showed significant 
differences (p<0.001) in both models, and CC10 signal was significantly different only in short term exposure. Ubiquitin staining was 
observed in IM and RM (N and P) in inflamed lung tissue, but to a lesser extent in placebo lung. 
 
 
Interestingly, the peak corresponding to m/z 6445 was identified as S100A6. This peak has been already detected 
but not identified in another SELDI-TOF-MS study on plasma samples from pregnant women with asthma [16]. 
The fact that such similarities can be found between a human study and our work on mouse model further 
supports the impact of our findings for potential human asthma applications. S100A6 is a member of the S100 
family of Ca2+-binding proteins and is associated with cell proliferation. The contribution of S100 A6 in the 
control of cell proliferation is potentially important in asthma-related airway remodeling process. Indeed, Breen 
et al have demonstrated that S100A6 is a potent inducer of fibroblasts proliferation [25]. Regarding S100A6, 
Western blot did not reveal significant enhancement of protein levels in allergen-exposed mice (Fig. 2A). 
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However, quantitative studies performed by immunohistochemistry confirmed that S100A6 protein was 
increased in allergen-exposed mice (p<0.0001) (Fig. 2B, panels I - L). 
In our study, Histone H4 protein levels were also unexpectedly found to be decreased in samples from allergen-
exposed animals. This difference was found by using CM10 protein chips but was also confirmed on IMAC 
chips study (data not shown). Further experiments should be conducted to assess potential Histone H4 
metabolism during asthma. Indeed, Histone H4 hyperacetylation might lead to production of proinflammatory 
mediators [26, 27]. 
As found in our SELDI-TOF-MS profile studies, Histone H4 Western blot signal was also significantly lower in 
allergen-exposed mice than in placebo mice (Fig. 2A). 
Finally, Ubiquitin was identified from the chronic remodeling mouse model by SELDI-TOF-MS as a relevant 
bio-marker. Ubiquitin was also found by SELDI-TOF-MS as a discriminant peak in acute inflammation model 
(percentage of importance 1.1% and p-value 3.6 x l0-4). Ubiquitin was detected as a monomer in our samples. 
This finding could suggest that the proteasome pathway is undergoing activation in the context of asthma-related 
inflammation participating in the inflammatory burden. This hypothesis is supported by the report of anti-
inflammatory effects of the proteasome inhibitor P-51 [28]. Ubiquitin should thus be further explored to assess 
its exact role in asthma-related inflammation. Western blot analysis showed increased protein expression in 
allergen-exposed mice in both acute and chronic models but protein levels were from far higher after allergen 
exposure in the acute inflammation model. By immunohistochemistry, ubiquitin was detected in nuclei from 
alveolar epithelial and parenchymal inflammatory cells (Fig. 2B, panels M-P). 
 
Figure 3. Confirmation of FIZZ-1 identification on CM10 array by specific immunodepletion. (A) Crude 
allergen exposed-mice lung extract; (B) FIZZ-1 immu-noprecipited with a FIZZ-1 antibody and eluted, using the 
same allergen exposed-mice lung protein extract; (C) negative control immunoprecipited and eluted fraction 
with a non-relevant antibody. 
 
 
4   Concluding remarks 
Taken together, our results show that new key biomarkers participating in the establishment of the asthmatic 
pheno-type can be unveiled by proteomic studies aiming at comparing peptides issued from healthy and disease 
tissues. Our results suggest that SELDI-TOF-MS is a useful tool to identify new potential therapeutic targets in 
inflammatory diseases such as asthma. 
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